CARAVITA, Sergio
 Distribuzione geografica
Continente #
EU - Europa 5.146
NA - Nord America 993
AS - Asia 268
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
AF - Africa 1
Totale 6.422
Nazione #
IE - Irlanda 2.890
US - Stati Uniti d'America 938
GB - Regno Unito 920
RU - Federazione Russa 576
IT - Italia 311
FR - Francia 272
SG - Singapore 117
SE - Svezia 72
CN - Cina 65
CA - Canada 54
DE - Germania 50
ID - Indonesia 36
FI - Finlandia 21
NL - Olanda 17
IN - India 16
KR - Corea 16
HK - Hong Kong 6
BG - Bulgaria 5
BR - Brasile 5
EU - Europa 5
ES - Italia 4
JP - Giappone 3
PK - Pakistan 3
AU - Australia 2
IR - Iran 2
NO - Norvegia 2
TR - Turchia 2
AT - Austria 1
BO - Bolivia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IL - Israele 1
JM - Giamaica 1
LU - Lussemburgo 1
MA - Marocco 1
RO - Romania 1
TW - Taiwan 1
UA - Ucraina 1
Totale 6.422
Città #
Dublin 2.861
Southend 840
Princeton 171
Boardman 98
Chandler 90
Moscow 77
Altamura 70
New York 63
Ashburn 58
Singapore 58
Toronto 50
Washington 48
Fairfield 45
Wilmington 44
Jakarta 36
Dalmine 35
Milan 29
Ogden 27
London 25
Los Angeles 21
Munich 16
Seoul 16
Bergamo 15
Amsterdam 14
Frankfurt am Main 13
Norwalk 13
Shenzhen 13
Pune 12
Guangzhou 11
Lappeenranta 11
Woodbridge 11
Andover 10
San Diego 10
Shanghai 10
Cambridge 9
Helsinki 9
Chiswick 7
Hounslow 7
Kilburn 7
Hangzhou 6
Chicago 5
Modena 5
Prescot 5
Sofia 5
Sorbolo 5
Mountain View 4
Naples 4
New Bedfont 4
Acton 3
Anacapri 3
Ann Arbor 3
Padova 3
Piacenza 3
Ribeirão Preto 3
Rome 3
Sarnthein 3
St Petersburg 3
Treviglio 3
Ankara 2
Atlanta 2
Beijing 2
Boston 2
Bremen 2
Buccheri 2
Carobbio degli Angeli 2
Catania 2
Cologno Monzese 2
Hong Kong 2
Houston 2
Islington 2
Juiz de Fora 2
Madison 2
Madrid 2
Malappuram 2
Melbourne 2
Mugnano di Napoli 2
Ningbo 2
Santa Clara 2
Seattle 2
Sesto Fiorentino 2
Southwark 2
Stuttgart 2
Wandsworth 2
Ancona 1
Archi 1
Asti 1
Beauharnois 1
Bologna 1
Borno 1
Bucharest 1
Bussero 1
Böblingen 1
Carrara 1
Casalmaggiore 1
Casavatore 1
Chennai 1
Chiyoda-ku 1
Cormano 1
Delhi 1
Duelmen 1
Totale 5.100
Nome #
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration? 111
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 106
Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader 103
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 103
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure with Preserved Ejection Fraction 100
Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study 99
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 99
Pulmonary arterial hypertension associated with a von Hippel-Lindau gene mutation 99
The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? 98
Reply to: ‘The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome’ 96
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 95
Proposta di una lettera di dimissione standardizzata dopo ospedalizzazione per embolia polmonare acuta 95
Assessment of left ventricular diastolic function by three-dimensional transthoracic echocardiography 91
Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore 89
Diagnostic and therapeutic models for the management of acute pulmonary embolism: An issue of local available resources 87
Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand 86
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component 86
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes 86
Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude 84
Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities 83
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure with Preserved Ejection Fraction? 83
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude: The High Altitude Cardiovascular Research-Andes Study 83
Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component 83
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 82
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 82
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database 82
Blood pressure at high altitude: Physiology and clinical implications 81
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 81
Exercise stress echocardiography of the pulmonary circulation and right ventricular-arterial coupling in healthy adolescents 80
Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: Effects antihypertensive combination treatment 80
ANMCO Position paper: Pulmonary circulation diseases and COVID-19 78
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 77
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 77
Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps project 77
Recent advances in multimodality imaging of the tricuspid valve 77
Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: From the compliance to adaptation, maladaptation and reflexes 76
Statement ANMCO: Tromboembolismo arterioso e venoso: quali implicazioni per la pratica clinica? 75
Decreased pulmonary vascular distensibility in adolescents conceived by in vitro fertilization 75
Stiff left atrial syndrome after low-dose radiotherapy for right breast cancer: The need for invasive hemodynamics at exercise 75
Blood pressure response in miners exposed to chronic intermittent hypoxia in Chile 74
Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction 73
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 73
Hyperparathyroidism in celiac disease: always secondary? 73
Understanding mechanisms of Fontan failure: exercise haemodynamics to unmask diastolic dysfunction, again! 72
Ipertensione polmonare pre-capillare o post-capillare? Il ruolo dei test provocativi in sala di emodinamica = Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab 72
Pulmonary vascular function and exercise capacity in black sub-Saharan Africans 72
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 72
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 72
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 72
Pulmonary arterial hypertension 70
Heart failure and sleep related breathing disorders: Data from PROMISES (Progetto Multicentrico Italiano Sonno e Scompenso Cardiaco) study 70
Noninvasive versus invasive pressure–flow relationship of the pulmonary circulation: Bias and error 70
Phenotyping long COVID 70
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 69
Heart failure with preserved ejection fraction and COVID-19: which comes first, the chicken or the egg? Letter regarding the article ‘Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings’ 69
Hemodynamic phenotyping of pulmonary hypertension in left heart failure 68
Heart failure and anemia: Effects on prognostic variables 67
CPET for Long COVID-19 65
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 65
Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease 63
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study 62
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 62
Obstructive Ventilatory Disorder in Heart Failure—Caused by the Heart or the Lung? 62
Association of outcome with left ventricular volumes and ejection fraction measured with two- and three-dimensional echocardiography in patients referred for routine, clinically indicated studies 61
Management of anticoagulant therapy in the follow-up of pulmonary embolism in clinical practice 60
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction 60
Takayasu arteritis with aortic coarctation and multiple stenosis of aortic branches 59
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease 58
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 57
Impact of COVID-19 lockdown on exercise capacity in PAH patients 57
Interatrial Shunt Devices 57
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity 57
The Conundrum of HFpEF Definition: Non-Invasive Assessment Uncertainties and Alternative Diagnostic Strategies 56
Incremental Value of Right Atrial Strain Analysis to Predict Atrial Fibrillation Recurrence after Electrical Cardioversion 56
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 56
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation 55
Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis 55
The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension 54
Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079)) 54
Clinical Value of a Novel Three-Dimensional Echocardiography–Derived Index of Right Ventricle–Pulmonary Artery Coupling in Tricuspid Regurgitation 53
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 52
Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation 52
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea 51
Blood pressure and high altitude: physiological response and clinical management 51
Why Do Exercise Hemodynamics Matter? 51
Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction 51
Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: A case report 50
Corrigendum to 'Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project' [Respir. Physiol. Neurobiol. 188, (2013), 223-228] 46
Personalized exercise prescription as a tool for hypertension management and cardiovascular prevention: Evidence and pending issues 45
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment 45
Cluster analysis of advanced invasive hemodynamics in heart failure with preserved ejection fraction 43
Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report 43
Alterations of cardiovascular complexity during acute exposure to high altitude: A multiscale entropy approach 40
Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 24
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 23
Exercise in hypoxia: a model from laboratory to on-field studies 23
Pulmonary Hypertension Associated with Left Heart Disease 20
Group 2 Pulmonary Hypertension: Clinical Features and Treatment 3
null 3
Totale 6.738
Categoria #
all - tutte 40.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/20221.433 79 300 213 14 120 179 90 58 83 96 154 47
2022/2023882 179 133 168 81 28 43 26 58 44 17 77 28
2023/20243.546 47 53 101 68 87 711 2.216 86 56 5 4 112
2024/2025859 102 248 85 356 68 0 0 0 0 0 0 0
Totale 6.738